{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:39:15Z","timestamp":1767591555492,"version":"3.48.0"},"reference-count":45,"publisher":"National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)","issue":"3","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. oncol."],"abstract":"<jats:p>Background. Synchronous metastatic liver disease (SLM) in colon cancer (CC) patients is an extremely unfavorable prognostic factor. The impact of lymph node ratio (LNR) and tumor burden score (TBS) on prognosis in this subset of patients remains incompletely understood. Aim. To assess the impact of LNR and TBS on survival in CC patients with synchronous LM who underwent staged or simultaneous surgery. Materials and Methods. A retrospective analysis of 365 patients with CC and SLM who underwent either staged or simultaneous surgical resection at the National Cancer Institute (Kyiv, Ukraine) between 2010 and 2024 was conducted. The demographic, clinicopathological, and survival data were analyzed. LNR was defined as the proportion of metastatic lymph nodes to total harvested lymph nodes, with a cutoff of 0.25. TBS was calculated using the Sasaki formula and categorized into three risk groups. Results. A mathematical model identified TBS clusters (p &lt; 0.04, HR = 1.8, 95% CI 1.1\u20142.3), the number of LM (p = 0.02, HR = 0.8, 95% CI 0.3\u20141.4), pN stage (p = 0.03, HR = 0.6, 95% CI 0.3\u20140.9), LNR (p = 0.005, HR = 3.1, 95% CI 2.2\u20144.2), and KRAS gene status (p = 0.01, HR = 1.1, 95% CI 1.1\u20141.3) as independent risk factors for overall survival. Conclusion. Lymph node ratio and tumor burden score allow us to argue the surgical strategy choice for CC patients with synchronous liver metastases who are candidates for surgical resection. The staged surgical strategy provided better oncological outcomes in CC patients with both high LNR and TBS.<\/jats:p>","DOI":"10.15407\/exp-oncology.2025.03.347","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T10:19:06Z","timestamp":1767521946000},"page":"347-355","source":"Crossref","is-referenced-by-count":0,"title":["SIMULTANEOUS VS STAGED RESECTIONS IN COLON CANCER PATIENTS WITH SYNCHRONOUS LIVER METASTASES: PROGNOSTIC IMPACT OF LYMPH NODE RATIO AND TUMOR BURDEN SCORE"],"prefix":"10.15407","volume":"47","author":[{"given":"A.","family":"Burlaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bezverkhnyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Bankovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Zvirych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Skyba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Beznosenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Lisnyy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sorokin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Yatsyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"32237","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Tonini V, Zanni M. Why is early detection of colon cancer still not possible in 2023? World J Gastroenterol. 202421;30(3):211-224. https:\/\/doi.org\/10.3748\/wjg.v30.i3.211","DOI":"10.3748\/wjg.v30.i3.211"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Burlaka A, Ryzhov A, Ostapenko y, et al. Twenty-year experience in liver surgery in metastatic colorectal pa- tients: a case series study in Ukraine. Ann Med Surg (Lond). 2023;85(5):1413-1419. https:\/\/doi.org\/10.1097\/MS9.0000000000000619","DOI":"10.1097\/MS9.0000000000000619"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller Kd, fuchs hE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021 Jan;71(1):7-33. https:\/\/doi.org\/10.3322\/caac.21654","DOI":"10.3322\/caac.21654"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Rahbari NN, Biondo S, frago R\u2026 SyNChRONOUS and CCRe-IV Trial Groups. Primary tumor resection before systemic therapy in patients with colon cancer and unresectable metastases: combined results of the SyNChRO- NOUS and CCRe-IV Trials. J Clin Oncol. 2024;42(13):1531-1541. https:\/\/doi.org\/10.1200\/JCO.23.01540","DOI":"10.1200\/JCO.23.01540"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Benson AB, Venook AP, Adam M, et al. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in On- cology. J Natl Compr Canc Netw. 2024;22(2d):e240029. https:\/\/doi.org\/10.6004\/jnccn.2024.0029","DOI":"10.6004\/jnccn.2024.0029"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Sijberden JP, Alvarez Escribano MS, Kasai M, et al. Perioperative safety and oncological efficacy of simultaneous versus colorectal and liver first two-staged resections in patients with synchronous colorectal liver metasta- ses: a systematic review and network meta-analysis. HPB (Oxford). 2025;27(2):135-149. https:\/\/doi.org\/10.1016\/j.hpb.2024.10.010","DOI":"10.1016\/j.hpb.2024.10.010"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Ghiasloo M, Pavlenko d, Verhaeghe M, et al. Surgical treatment of stage IV colorectal cancer with synchronous liver metastases: A systematic review and network meta-analysis. Eur J Surg Oncol. 2020;46(7):1203-1213. https:\/\/doi.org\/10.1016\/j.ejso.2020.02.040.","DOI":"10.1016\/j.ejso.2020.02.040"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Minagawa M, yamamoto J, Miwa S, et al. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg. 2006;141(10):1006-1012; discussion 1013. https:\/\/doi.org\/10.1001\/archsurg.141.10.1006","DOI":"10.1001\/archsurg.141.10.1006"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Hajibandeh S, Hajibandeh S, Sultana A, et al. Simultaneous versus staged colorectal and hepatic resections for colorectal cancer with synchronous hepatic metastases: a meta-analysis of outcomes and clinical characteristics. Int J Colorectal Dis. 2020;35(9):1629-1650. https:\/\/doi.org\/10.1007\/s00384-020-03694-9","DOI":"10.1007\/s00384-020-03694-9"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Reddy SK, Pawlik TM, Zorzi d, et al. Simultaneous resections of colorectal cancer and synchronous liver metas- tases: a multi-institutional analysis. Ann Surg Oncol. 2007;14(12):3481-3491. https:\/\/doi.org\/10.1245\/s10434-007- 9522-5","DOI":"10.1245\/s10434-007-9522-5"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Guerra f, Giuliani G, Saccucci G, Coratti A. Simultaneous, single-docking robotic resection for right colon cancer with synchronous liver metastases. Surg Oncol. 2022;43:101816. https:\/\/doi.org\/10.1016\/j.suronc.2022.101816","DOI":"10.1016\/j.suronc.2022.101816"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Boudjema K, Locher C, Sabbagh C, \u2026 METASyNC Study group. Simultaneous versus delayed resection for ini- tially resectable synchronous colorectal cancer liver metastases: A prospective, open-label, randomized, controlled trial. Ann Surg. 2021;273(1):49-56. https:\/\/doi.org\/10.1097\/SLA.0000000000003848. PMId: 32209911","DOI":"10.1097\/SLA.0000000000003848"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Nassar A, Tzedakis S, dhote A, et al. Multiple laparoscopic liver resection for colorectal liver metastases. Cancers (Basel). 2023;15(2):435. https:\/\/doi.org\/10.3390\/cancers15020435","DOI":"10.3390\/cancers15020435"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Burlaka A, Rozhkova V, Pavliuk R, et al. Laennec's approach for central liver resection of colorectal cancer liver metastasis adjacent to the hepatic hilum that occurred 10 years after colectomy: A case report. Int J Surg Case Rep. 2024;116:109327. https:\/\/doi.org\/10.1016\/j.ijscr.2024.109327","DOI":"10.1016\/j.ijscr.2024.109327"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Paro A, hyer MJ, Tsilimigras dI, et al. Machine learning approach to stratifying prognosis relative to tumor burden after resection of colorectal liver metastases: an international cohort analysis. J Am Coll Surg. 2022;234(4):504-513. https:\/\/doi.org\/10.1097\/XCS.0000000000000094","DOI":"10.1097\/XCS.0000000000000094"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Torzilli G, Adam R, Vigan\u00f2 L, et al. Surgery of colorectal liver metastases: pushing the limits. Liver Cancer. 2016;6(1):80-89. https:\/\/doi.org\/10.1159\/000449495","DOI":"10.1159\/000449495"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Zhou h, Liu Z, Wang y, et al. Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduct Target Ther. 2022;7(1):70. https:\/\/doi.org\/10.1038\/s41392-022-00922-2","DOI":"10.1038\/s41392-022-00922-2"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Cotan hT, Emilescu RA, Iaciu CI,et al. Prognostic and predictive determinants of colorectal cancer: a comprehen- sive review. Cancers (Basel). 2024;16(23):3928. https:\/\/doi.org\/10.3390\/cancers16233928","DOI":"10.3390\/cancers16233928"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Yonekawa Y, Uehara K, Mizuno T, et al. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score. Int J Clin Oncol. 2021;26(1):126-134. https:\/\/doi.org\/10.1007\/s10147-020-01793-9","DOI":"10.1007\/s10147-020-01793-9"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Beirat Af, Amarin JZ, Suradi hh, et al. Lymph node ratio is a more robust predictor of overall survival than N stage in stage III colorectal adenocarcinoma. Diagn Pathol. 2024;19(1):44. https:\/\/doi.org\/10.1186\/s13000-024-01449-6","DOI":"10.1186\/s13000-024-01449-6"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Nawras M, Chawla K, deRiso A, et al. The effect of preoperative endoscopic tattooing on lymph node retrie- val in colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2023;38(1):166. https:\/\/doi. org\/10.1007\/s00384-023-04466-x","DOI":"10.1007\/s00384-023-04466-x"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Sasaki K, Margonis GA, Andreatos N, et al. The prognostic utility of the \u00abTumor Burden Score\u00bb based on preopera- tive radiographic features of colorectal liver metastases. J Surg Oncol. 2017;116(4):515-523. https:\/\/doi.org\/10.1002\/ jso.24678","DOI":"10.1002\/jso.24678"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Ahmad A, Reha J, Saied A, et al. Association of primary tumor lymph node ratio with burden of liver metastases and survival in stage IV colorectal cancer. Hepatobiliary Surg Nutr. 2017;6(3):154-161. https:\/\/doi.org\/10.21037\/ hbsn.2016.08.08","DOI":"10.21037\/hbsn.2016.08.08"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Sasaki K, Morioka d, Conci S, et al. The tumor burden score: a new \u00abmetro-ticket\u00bb prognostic tool for colorectal li- ver metastases based on tumor size and number of tumors. Ann Surg. 2018;267(1):132-141. https:\/\/doi.org\/10.1097\/ SLA.0000000000002064","DOI":"10.1097\/SLA.0000000000002064"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Nagino M, deMatteo R, Lang h, et al. Proposal of a new comprehensive notation for hepatectomy: The \u00abnew world\u00bb terminology. Ann Surg. 2021;274(1):1-3. https:\/\/doi.org\/10.1097\/SLA.0000000000004808","DOI":"10.1097\/SLA.0000000000004808"},{"key":"ref25","unstructured":"National Comprehensive Cancer Network. (2025). Colon cancer. Retrieved from https:\/\/www.nccn.org\/ login?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Stewart CL, Warner S, Ito K, et al. Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure? Curr Probl Surg. 2018;55(9):330-379. https:\/\/doi.org\/10.1067\/j.cpsurg.2018.08.004","DOI":"10.1067\/j.cpsurg.2018.08.004"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Lin Q, ding K, Zhao R, et al. Preoperative chemotherapy prior to primary tumour resection for asymptomatic syn- chronous unresectable colorectal liver-limited metastases: The RECUT multicenter randomised controlled trial. Eur J Cancer. 2023;191:112961. https:\/\/doi.org\/10.1016\/j.ejca.2023.112961","DOI":"10.1016\/j.ejca.2023.112961"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Tepelenis K, Pappas-Gogos G, Ntellas P, et al. The role of preoperative chemotherapy in the management of syn- chronous resectable colorectal liver metastases: a meta-analysis. Curr Oncol. 2023;30(5):4499-4511. https:\/\/doi. org\/10.3390\/curroncol30050340","DOI":"10.3390\/curroncol30050340"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Colletti G, Ciniselli CM, Sorrentino L, et al. Multimodal treatment of rectal cancer with resectable synchronous liver metastases: A systematic review. Dig Liver Dis. 2023;55(12):1602-1610. https:\/\/doi.org\/10.1016\/j.dld.2023.05.023","DOI":"10.1016\/j.dld.2023.05.023"},{"key":"ref30","unstructured":"National Comprehensive Cancer Network. NCCN Guidelines Version 6.2024 Colon Cancer. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf.28-jan-2025."},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Kasai S, Ashida R, Sugiura T, et al. Long-term outcomes of staged liver resection for synchronous liver metastases from colorectal cancer and the clinical impact of early recurrence: A single-center retrospective cohort study. Ann Gastroenterol Surg. 2022;7(2):318-325. https:\/\/doi.org\/10.1002\/ags3.12628","DOI":"10.1002\/ags3.12628"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Kim hh, Nguyen Nh, yang CJ, et al. Outcomes of simultaneous versus staged resection for stage IV colorectal cancer with synchronous liver metastases. Am Surg. 2024;90(10):2367-2373. https:\/\/doi.org\/10.1177\/00031348241244632","DOI":"10.1177\/00031348241244632"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Machairas N, di Martino M, Primavesi f, et al. Simultaneous resection for colorectal cancer with synchronous liver metastases: current state-of-the-art. J Gastrointest Surg. 2024;28(4):577-586. https:\/\/doi.org\/10.1016\/j.gas- sur.2024.01.034","DOI":"10.1016\/j.gassur.2024.01.034"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Wang Sh, Song L, Tang Jy, et al. Safety and long-term prognosis of simultaneous versus staged resection in synchro- nous colorectal cancer with liver metastasis: a systematic review and meta-analysis. Eur J Med Res. 2022;27(1):297. https:\/\/doi.org\/10.1186\/s40001-022-00937-z","DOI":"10.1186\/s40001-022-00937-z"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Conci S, Ruzzenente A, Pedrazzani C, et al. Simultaneous approach for patients with synchronous colon and rectal liver metastases: Impact of site of primary on postoperative and oncological outcomes. Eur J Surg Oncol. 2021;47(4):842-849. https:\/\/doi.org\/10.1016\/j.ejso.2020.09.015","DOI":"10.1016\/j.ejso.2020.09.015"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Serrano PE, Parpia S, Karanicolas P, et al. Simultaneous resection for synchronous colorectal cancer liver metasta- ses: A feasibility clinical trial. J Surg Oncol. 2022;125(4):671-677. https:\/\/doi.org\/10.1002\/jso.26764","DOI":"10.1002\/jso.26764"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Jiao S, Guan X, Zhang W, et al. Prognostic impact of increased lymph node yield in colorectal cancer patients with synchronous liver metastasis: a population-based retrospective study of the US database and a Chinese registry. Int J Surg. 2023;109(7):1932-1940. https:\/\/doi.org\/10.1097\/JS9.0000000000000244","DOI":"10.1097\/JS9.0000000000000244"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Leong SP, Naxerova K, Keller L, et al. Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels. Clin Exp Metastasis. 2022;39:159-179. https:\/\/doi.org\/10.1007\/s10585-021-10120-z","DOI":"10.1007\/s10585-021-10120-z"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Wang L, Song B, Chen y, hirano y. d3 lymph node dissection improves the survival outcome in patients with pT2 colorectal cancer. Int J Colorectal Dis. 2023;38(1):30. https:\/\/doi.org\/10.1007\/s00384-023-04326-8","DOI":"10.1007\/s00384-023-04326-8"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Naidu K, Chapuis Ph, Connell L, et al. Lymph node ratio prognosticates overall survival in patients with stage IV colorectal cancer. Tech Coloproctol. 2024;28(1):115. https:\/\/doi.org\/10.1007\/s10151-024-02984-6.","DOI":"10.1007\/s10151-024-02984-6"},{"key":"ref41","unstructured":"Naxerova K, Reiter JG, Brachtel E, et al. Origins of lymphatic and distant metastases in human colorectal cancer."},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Science. 2017;357(6346):55-60. https:\/\/doi.org\/10.1126\/science.aai8515","DOI":"10.1126\/science.aai8515"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Zhang y, Wu d, Zhang Z, et al. Impact of lymph node metastasis on immune microenvironment and prognosis in colorectal cancer liver metastasis: insights from multiomics profiling. Br J Cancer. 2025;132:513-524. https:\/\/doi. org\/10.1038\/s41416-024-02921-2","DOI":"10.1038\/s41416-024-02921-2"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"O'Connell RM, hoti E. Challenges and opportunities for precision surgery for colorectal liver metastases. Cancers (Basel). 2024;16(13):2379. https:\/\/doi.org\/10.3390\/cancers16132379","DOI":"10.3390\/cancers16132379"}],"container-title":["Experimental Oncology"],"original-title":[],"link":[{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/541\/438","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/541\/438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:34:28Z","timestamp":1767591268000},"score":1,"resource":{"primary":{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/view\/541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12,30]]}},"URL":"https:\/\/doi.org\/10.15407\/exp-oncology.2025.03.347","relation":{},"ISSN":["2312-8852","1812-9269"],"issn-type":[{"type":"electronic","value":"2312-8852"},{"type":"print","value":"1812-9269"}],"subject":[],"published":{"date-parts":[[2025,12,30]]}}}